Navigating 7 Analyst Ratings For Chemours

浏览7个Chemours 分析师评级

Benzinga · 2024/09/26 00:00 · 评级/大行评级

Across the recent three months, 7 analysts have shared their insights on Chemours (NYSE:CC), expressing a variety of opinions spanning from bullish to bearish.

在最近的三个月中，有7位分析师就The Chemours (纽交所:CC)发表了他们的见解，表达了从看好到看淡的各种观点。

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $24.57, a high estimate of $30.00, and a low estimate of $18.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.58%.

分析师通过对12个月价格目标的评估提供更深入的见解，显示出平均目标为24.57美元，高估为30.00美元，低估为18.00美元。情绪出现负向转变，因分析师已将平均目标降低了13.58%。

Investigating Analyst Ratings: An Elaborate Study

分析师评级的调查：一项详尽的研究

An in-depth...

Navigating 7 Analyst Ratings For Chemours

Navigating 7 Analyst Ratings For Chemours

风险及免责提示

声明